Teva Fails To Get $110M Drug Contract Suit Tossed
Teva is unable to dodge a $110 million case claiming that it botched the marketing and sale of the muscle relaxant Amrix, after a Virginia federal judge found the suit at...To view the full article, register now.
Already a subscriber? Click here to view full article